LivaNova PLC Stock Price, News & Analysis (NASDAQ:LIVN)

$84.32 0.04 (0.05 %)
(As of 11/18/2017 03:47 AM ET)
Previous Close$84.32
Today's Range$84.91 - $83.44
52-Week Range$42.76 - $84.91
Volume167,726 shs
Average Volume390,294 shs
Market Capitalization$3.97 billion
P/E Ratio23.64
Dividend YieldN/A
BetaN/A

About LivaNova PLC (NASDAQ:LIVN)

LivaNova PLC logoLivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company's segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Cardiac Rhythm Management segment is engaged in the development, manufacturing and marketing of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Cardiac Rhythm Management products include high-voltage defibrillators Cardiac Resynchronization Therapy device (CRT-D) and low-voltage pacemakers. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression.


Industry, Sector and Symbol:
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Sector: Medical Equipment, Supplies & Distribution - NEC
  • Symbol: NASDAQ:LIVN
  • CUSIP: N/A
  • Web: www.livanova.comhome.action
Debt:
  • Debt-to-Equity Ratio: 0.04%
  • Current Ratio: 2.03%
  • Quick Ratio: 1.42%
Price-To-Earnings:
  • Trailing P/E Ratio: 23.64
  • Forward P/E Ratio: 25.32
  • P/E Growth: 2.46
Sales & Book Value:
  • Annual Sales: $1.2139 billion
  • Price / Sales: 3.35
  • Cash Flow: $5.57 per share
  • Price / Cash: 15.15
  • Book Value: $39.71 per share
  • Price / Book: 2.12
Profitability:
  • Trailing EPS: $3.75
  • Net Income: ($62,780,000.00)
  • Net Margins: 4.63%
  • Return on Equity: 9.33%
  • Return on Assets: 6.82%
Misc:
  • Employees: 4,500
  • Outstanding Shares: 48,210,000
 

Frequently Asked Questions for LivaNova PLC (NASDAQ:LIVN)

What is LivaNova PLC's stock symbol?

LivaNova PLC trades on the NASDAQ under the ticker symbol "LIVN."

How were LivaNova PLC's earnings last quarter?

LivaNova PLC (NASDAQ:LIVN) posted its quarterly earnings results on Thursday, November, 2nd. The company reported $0.93 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.76 by $0.17. The business earned $309.70 million during the quarter, compared to the consensus estimate of $301.22 million. LivaNova PLC had a net margin of 4.63% and a return on equity of 9.33%. The company's quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.78 earnings per share. View LivaNova PLC's Earnings History.

When will LivaNova PLC make its next earnings announcement?

LivaNova PLC is scheduled to release their next quarterly earnings announcement on Wednesday, March, 7th 2018. View Earnings Estimates for LivaNova PLC.

What guidance has LivaNova PLC issued on next quarter's earnings?

LivaNova PLC issued an update on its FY17 earnings guidance on Thursday, November, 2nd. The company provided earnings per share guidance of $3.30-3.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.24.

Where is LivaNova PLC's stock going? Where will LivaNova PLC's stock price be in 2017?

7 brokers have issued 12 month price objectives for LivaNova PLC's stock. Their predictions range from $50.00 to $91.00. On average, they expect LivaNova PLC's stock price to reach $76.83 in the next twelve months. View Analyst Ratings for LivaNova PLC.

What are Wall Street analysts saying about LivaNova PLC stock?

Here are some recent quotes from research analysts about LivaNova PLC stock:

  • 1. Canaccord Genuity analysts commented, "We stay HOLD rated on LIVN coming out of constructive meetings with management on the road last week. We continue to believe the firm possesses intriguing long-term growth initiatives –in transcatheter mitral valve replacement (TMVR), heart failure (HF) and treatment-resistant depression (TRD) – but anticipate these segments will take several years to materialize and likely require additional M&A and material R&D spending before either the TMVR or HF initiatives could potentially contribute to LIVN’s top- and bottom-line growth profiles. That said, we sensed incrementally stronger conviction from management regarding both robust GM expansion potential as well as low-DD revenue growth from the emerging markets (ROW) business. Taken together, we management seems confident it can deliver merger integration cost synergies that the think these drivers could help the firm hit or exceed its guidance in 4Q:17." (11/14/2017)
  • 2. According to Zacks Investment Research, "LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London, United Kingdom. " (11/9/2017)
  • 3. Needham & Company LLC analysts commented, "LIVN announced that it is exploring strategic options for its low growth and low margin CRM business. This shouldn’t come as a huge surprise since management had previously hinted a potential sale of the CRM business. We think a CRM sale would increase LIVN’s revenue growth; the EPS impact hinges on price, CRM margins, and use of proceeds. We think a sale would be neutral to slightly dilutive if the proceeds were used for share repurchases and/or debt repayment though we note that there would likely be near-term hit to EPS between when the sale is announced and when LIVN is able to deploy the proceeds to offset any dilution." (9/14/2017)
  • 4. BTIG Research analysts commented, "Last week, while we were at our Snowbird conference, LIVN reported Q4 results and released initial FY17 guidance. Once again, we are lowering our estimates for LIVN. While shares are inexpensive, we do not see how it will grow in the future unless major M&A or R&D efforts take place, moving LIVN into new markets. Given most of LIVN’s markets are flat to declining, we would be inclined to wait for the company to show intentions to enter new markets before recommending shares. We don’t expect an inflection point on cardiac surgery anytime soon and while new iterations in Neuromod may pad growth in 2H17, we think the lower end of the 1-3% revenue growth guidance would be a good achievement. There remain considerable areas of opportunity on the synergy side, which should support EPS growth. With the first innings of physical integration behind them, we think the co. is in a better position to focus on more sizeable areas of savings such as purchasing/direct procurement. However, we think the lack of revenue growth is more important than synergies and we reiterate our Neutral rating." (3/10/2017)

Who are some of LivaNova PLC's key competitors?

Who owns LivaNova PLC stock?

LivaNova PLC's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (2.73%), Bank of New York Mellon Corp (1.10%), NWQ Investment Management Company LLC (1.04%), Wells Fargo & Company MN (0.82%), American Century Companies Inc. (0.80%) and New York State Common Retirement Fund (0.62%). Company insiders that own LivaNova PLC stock include Alfred J Novak, Daniel Jeffrey Moore, Hugh M Morrison, Jacques Gutedel, Sharon O'kane and Two SCA Equinox. View Institutional Ownership Trends for LivaNova PLC.

Who sold LivaNova PLC stock? Who is selling LivaNova PLC stock?

LivaNova PLC's stock was sold by a variety of institutional investors in the last quarter, including Third Avenue Management LLC, Janus Henderson Group PLC, Stifel Financial Corp, KBC Group NV, Investment Counselors of Maryland LLC, Epoch Investment Partners Inc., Allianz Asset Management GmbH and Rock Point Advisors LLC. Company insiders that have sold LivaNova PLC company stock in the last year include Alfred J Novak, Daniel Jeffrey Moore and Hugh M Morrison. View Insider Buying and Selling for LivaNova PLC.

Who bought LivaNova PLC stock? Who is buying LivaNova PLC stock?

LivaNova PLC's stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, American Century Companies Inc., NWQ Investment Management Company LLC, Hosking Partners LLP, New York State Common Retirement Fund, Fisher Asset Management LLC, Retirement Systems of Alabama and PEAK6 Investments L.P.. View Insider Buying and Selling for LivaNova PLC.

How do I buy LivaNova PLC stock?

Shares of LivaNova PLC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LivaNova PLC's stock price today?

One share of LivaNova PLC stock can currently be purchased for approximately $84.32.

How big of a company is LivaNova PLC?

LivaNova PLC has a market capitalization of $3.97 billion and generates $1.2139 billion in revenue each year. The company earns ($62,780,000.00) in net income (profit) each year or $3.75 on an earnings per share basis. LivaNova PLC employs 4,500 workers across the globe.

How can I contact LivaNova PLC?

LivaNova PLC's mailing address is 20 Eastbourne Terrace, LONDON, W2 6LG, United Kingdom. The company can be reached via phone at +44-20-37865275 or via email at investor.relations@livanova.com.


MarketBeat Community Rating for LivaNova PLC (NASDAQ LIVN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  184
MarketBeat's community ratings are surveys of what our community members think about LivaNova PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for LivaNova PLC (NASDAQ:LIVN)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings, 4 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: $76.83 (8.88% downside)

Consensus Price Target History for LivaNova PLC (NASDAQ:LIVN)

Price Target History for LivaNova PLC (NASDAQ:LIVN)

Analysts' Ratings History for LivaNova PLC (NASDAQ:LIVN)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/14/2017Canaccord GenuityReiterated RatingHold$76.00N/AView Rating Details
11/7/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
11/3/2017Piper Jaffray CompaniesReiterated RatingBuy$85.00N/AView Rating Details
11/3/2017Jefferies Group LLCBoost Price TargetBuy$80.00 -> $91.00N/AView Rating Details
11/3/2017Needham & Company LLCBoost Price TargetBuy -> Buy$83.00 -> $89.00N/AView Rating Details
8/15/2017WBB SecuritiesDowngradeHold -> Sell$50.00LowView Rating Details
8/11/2017Berenberg BankReiterated RatingBuy$70.00LowView Rating Details
2/29/2016Kepler Capital MarketsBoost Price TargetHold$63.00 -> $66.00N/AView Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History and Estimates Chart for LivaNova PLC (NASDAQ:LIVN)

Earnings by Quarter for LivaNova PLC (NASDAQ:LIVN)

Earnings History by Quarter for LivaNova PLC (NASDAQ LIVN)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018        
11/2/2017Q3 2017$0.76$0.93$301.22 million$309.70 millionViewN/AView Earnings Details
8/9/2017Q2 2017$0.82$1.01$315.75 million$321.40 millionViewListenView Earnings Details
5/3/20173/31/2017$0.68$0.71$285.10 millionViewListenView Earnings Details
3/1/2017Q416$0.79$0.82$301.45 million$310.60 millionViewListenView Earnings Details
11/2/2016Q316$0.76$0.78$299.40 million$295.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for LivaNova PLC (NASDAQ:LIVN)
2017 EPS Consensus Estimate: $1.46
2018 EPS Consensus Estimate: $3.70
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20171$0.75$0.75$0.75
Q4 20171$0.71$0.71$0.71
Q1 20181$0.81$0.81$0.81
Q2 20181$0.98$0.98$0.98
Q3 20181$0.91$0.91$0.91
Q4 20181$1.00$1.00$1.00
(Data provided by Zacks Investment Research)

Dividends

Dividend History for LivaNova PLC (NASDAQ:LIVN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for LivaNova PLC (NASDAQ LIVN)

Insider Ownership Percentage: 0.28%
Institutional Ownership Percentage: 82.20%
Insider Trades by Quarter for LivaNova PLC (NASDAQ:LIVN)
Institutional Ownership by Quarter for LivaNova PLC (NASDAQ:LIVN)

Insider Trades by Quarter for LivaNova PLC (NASDAQ LIVN)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/15/2017Daniel Jeffrey MooreDirectorSell1,000$81.39$81,390.00View SEC Filing  
10/16/2017Daniel Jeffrey MooreDirectorSell1,000$74.58$74,580.00View SEC Filing  
9/15/2017Daniel Jeffrey MooreDirectorSell1,000$68.55$68,550.00View SEC Filing  
8/15/2017Daniel Jeffrey MooreDirectorSell1,000$60.76$60,760.00View SEC Filing  
7/17/2017Daniel Jeffrey MooreDirectorSell1,000$61.55$61,550.00View SEC Filing  
6/15/2017Daniel Jeffrey MooreDirectorSell1,000$60.80$60,800.00View SEC Filing  
5/23/2017Sharon O'kaneDirectorBuy1,000$58.58$58,580.00View SEC Filing  
5/22/2017Alfred J NovakDirectorSell1,000$58.49$58,490.00View SEC Filing  
5/5/2017Hugh M MorrisonDirectorSell3,215$55.89$179,686.35View SEC Filing  
4/17/2017Daniel Jeffrey MooreDirectorSell1,000$51.32$51,320.00View SEC Filing  
3/15/2017Daniel Jeffrey MooreDirectorSell1,000$50.21$50,210.00View SEC Filing  
9/22/2016Two S.C.A. EquinoxMajor ShareholderSell185,000$61.54$11,384,900.00View SEC Filing  
9/21/2016Two S.C.A. EquinoxMajor ShareholderSell391,379$60.69$23,752,791.51View SEC Filing  
9/16/2016Two S.C.A. EquinoxMajor ShareholderSell75,213$59.86$4,502,250.18View SEC Filing  
9/13/2016Two S.C.A. EquinoxMajor ShareholderSell25,408$60.02$1,524,988.16View SEC Filing  
9/8/2016Two S.C.A. EquinoxMajor ShareholderSell208,000$60.52$12,588,160.00View SEC Filing  
8/9/2016Jacques GutedelInsiderSell4,000$60.52$242,080.00View SEC Filing  
5/24/2016Daniel Jeffrey MooreDirectorSell1,000$50.07$50,070.00View SEC Filing  
5/19/2016Hugh M MorrisonDirectorSell3,600$48.00$172,800.00View SEC Filing  
5/6/2016Alfred J NovakDirectorSell4,000$51.12$204,480.00View SEC Filing  
4/15/2016Daniel Jeffrey MooreDirectorSell1,000$54.81$54,810.00View SEC Filing  
3/15/2016Daniel Jeffrey MooreDirectorSell1,000$56.88$56,880.00View SEC Filing  
2/16/2016Daniel Jeffrey MooreDirectorSell1,000$56.88$56,880.00View SEC Filing  
1/15/2016Daniel Jeffrey MooreDirectorSell1,000$52.64$52,640.00View SEC Filing  
12/15/2015Daniel Jeffrey MooreDirectorSell2,500$53.97$134,925.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for LivaNova PLC (NASDAQ LIVN)

Source:
DateHeadline
LivaNova PLC (LIVN) Director Sells $81,390.00 in StockLivaNova PLC (LIVN) Director Sells $81,390.00 in Stock
www.americanbankingnews.com - November 16 at 4:50 PM
LivaNova PLCs (LIVN) Hold Rating Reaffirmed at Canaccord GenuityLivaNova PLC's (LIVN) Hold Rating Reaffirmed at Canaccord Genuity
www.americanbankingnews.com - November 14 at 11:03 PM
LivaNova to Present at the Piper Jaffray and Berenberg ConferencesLivaNova to Present at the Piper Jaffray and Berenberg Conferences
finance.yahoo.com - November 8 at 2:01 PM
LivaNova PLC (LIVN) Receives Consensus Recommendation of "Hold" from AnalystsLivaNova PLC (LIVN) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 6 at 8:04 AM
FY2017 Earnings Estimate for LivaNova PLC Issued By Jefferies Group (LIVN)FY2017 Earnings Estimate for LivaNova PLC Issued By Jefferies Group (LIVN)
www.americanbankingnews.com - November 6 at 4:36 AM
LivaNova PLC (LIVN) Given New $89.00 Price Target at Needham & Company LLCLivaNova PLC (LIVN) Given New $89.00 Price Target at Needham & Company LLC
www.americanbankingnews.com - November 5 at 8:56 PM
Jefferies Group LLC Boosts LivaNova PLC (LIVN) Price Target to $91.00Jefferies Group LLC Boosts LivaNova PLC (LIVN) Price Target to $91.00
www.americanbankingnews.com - November 5 at 10:06 AM
LivaNova PLCs (LIVN) "Buy" Rating Reiterated at Piper Jaffray CompaniesLivaNova PLC's (LIVN) "Buy" Rating Reiterated at Piper Jaffray Companies
www.americanbankingnews.com - November 3 at 10:46 PM
Livanova PLC to Host Earnings CallLivanova PLC to Host Earnings Call
finance.yahoo.com - November 3 at 7:52 PM
LivaNova PLC (LIVN) Raised to Buy at ValuEngineLivaNova PLC (LIVN) Raised to Buy at ValuEngine
www.americanbankingnews.com - November 3 at 12:46 AM
LivaNova PLC (LIVN) Issues  Earnings ResultsLivaNova PLC (LIVN) Issues Earnings Results
www.americanbankingnews.com - November 2 at 6:44 PM
Reviewing Nevro Corp. (NVRO) & LivaNova PLC (LIVN)Reviewing Nevro Corp. (NVRO) & LivaNova PLC (LIVN)
www.americanbankingnews.com - November 2 at 3:18 PM
LivaNova PLC (LIVN) Updates FY17 Earnings GuidanceLivaNova PLC (LIVN) Updates FY17 Earnings Guidance
www.americanbankingnews.com - November 2 at 9:52 AM
LivaNova Recognizes Epilepsy Awareness Month This NovemberLivaNova Recognizes Epilepsy Awareness Month This November
finance.yahoo.com - November 2 at 5:36 AM
LivaNova PLC (LIVN) & Its Peers Critical ReviewLivaNova PLC (LIVN) & Its Peers Critical Review
www.americanbankingnews.com - October 31 at 1:06 PM
LivaNova PLC (LIVN) Scheduled to Post Quarterly Earnings on ThursdayLivaNova PLC (LIVN) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - October 26 at 5:00 AM
ETFs with exposure to LivaNova Plc : October 20, 2017ETFs with exposure to LivaNova Plc : October 20, 2017
finance.yahoo.com - October 21 at 6:10 AM
LivaNova PLC (LIVN) vs. Its Rivals Financial ContrastLivaNova PLC (LIVN) vs. Its Rivals Financial Contrast
www.americanbankingnews.com - October 21 at 4:24 AM
Daniel Jeffrey Moore Sells 1,000 Shares of LivaNova PLC (LIVN) StockDaniel Jeffrey Moore Sells 1,000 Shares of LivaNova PLC (LIVN) Stock
www.americanbankingnews.com - October 17 at 7:48 PM
LivaNova PLC (LIVN) Given Average Recommendation of "Hold" by BrokeragesLivaNova PLC (LIVN) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - October 12 at 6:58 AM
ETFs with exposure to LivaNova Plc : October 9, 2017ETFs with exposure to LivaNova Plc : October 9, 2017
finance.yahoo.com - October 9 at 4:29 PM
LivaNova Plc :LIVN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017LivaNova Plc :LIVN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 7 at 2:36 AM
Head to Head Analysis: LivaNova PLC (LIVN) versus Its CompetitorsHead to Head Analysis: LivaNova PLC (LIVN) versus Its Competitors
www.americanbankingnews.com - October 4 at 2:36 PM
LivaNova and MicroPort Announce the Approval of Rega Pacemakers by the China Food and Drug AdministrationLivaNova and MicroPort Announce the Approval of Rega Pacemakers by the China Food and Drug Administration
finance.yahoo.com - September 28 at 1:58 AM
LivaNova Announces U.S. Launch of Optiflow Arterial Cannulae FamilyLivaNova Announces U.S. Launch of Optiflow Arterial Cannulae Family
finance.yahoo.com - September 25 at 7:03 PM
Head-To-Head Survey: LivaNova PLC (LIVN) versus CryoLife (CRY)Head-To-Head Survey: LivaNova PLC (LIVN) versus CryoLife (CRY)
www.americanbankingnews.com - September 25 at 2:36 PM
LivaNova PLC (LIVN) Stock Rating Reaffirmed by Canaccord GenuityLivaNova PLC (LIVN) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - September 20 at 9:42 AM
LivaNova PLC (LIVN) Director Daniel Jeffrey Moore Sells 1,000 SharesLivaNova PLC (LIVN) Director Daniel Jeffrey Moore Sells 1,000 Shares
www.americanbankingnews.com - September 19 at 4:28 PM
LivaNova PLC (LIVN) Receives Consensus Rating of "Hold" from AnalystsLivaNova PLC (LIVN) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - September 17 at 9:02 AM
LivaNova PLC (LIVN) Lifted to Buy at Needham & Company LLCLivaNova PLC (LIVN) Lifted to Buy at Needham & Company LLC
www.americanbankingnews.com - September 16 at 8:26 PM
LivaNova PLC (LIVN) PT Raised to $80.00LivaNova PLC (LIVN) PT Raised to $80.00
www.americanbankingnews.com - September 15 at 2:34 PM
LivaNova PLC (LIVN) Upgraded at Needham & Company LLCLivaNova PLC (LIVN) Upgraded at Needham & Company LLC
www.americanbankingnews.com - September 15 at 8:30 AM
LivaNova Defines Strategic Outlook at Investor DayLivaNova Defines Strategic Outlook at Investor Day
finance.yahoo.com - September 15 at 5:56 AM
LivaNova to Explore Strategic Options for Cardiac Rhythm Management Business FranchiseLivaNova to Explore Strategic Options for Cardiac Rhythm Management Business Franchise
finance.yahoo.com - September 14 at 7:11 AM
LivaNova PLC (LIVN) Now Covered by Analysts at Piper Jaffray CompaniesLivaNova PLC (LIVN) Now Covered by Analysts at Piper Jaffray Companies
www.americanbankingnews.com - September 12 at 12:34 PM
LivaNova Announces Publication of Literature Review Highlighting the Clinical Value and Safety of the Perceval Sutureless Valve for Aortic Valve ReplacementLivaNova Announces Publication of Literature Review Highlighting the Clinical Value and Safety of the Perceval Sutureless Valve for Aortic Valve Replacement
finance.yahoo.com - September 11 at 10:33 PM
Jefferies Group Comments on LivaNova PLCs Q3 2017 Earnings (LIVN)Jefferies Group Comments on LivaNova PLC's Q3 2017 Earnings (LIVN)
www.americanbankingnews.com - September 11 at 1:42 AM
LivaNova PLC (LIVN) Coverage Initiated by Analysts at Jefferies Group LLCLivaNova PLC (LIVN) Coverage Initiated by Analysts at Jefferies Group LLC
www.americanbankingnews.com - September 8 at 8:42 PM
LivaNova Plc breached its 50 day moving average in a Bearish Manner : LIVN-US : August 29, 2017LivaNova Plc breached its 50 day moving average in a Bearish Manner : LIVN-US : August 29, 2017
finance.yahoo.com - August 30 at 6:07 AM
Analyzing LivaNova PLC (LIVN) and Align Technology (ALGN)Analyzing LivaNova PLC (LIVN) and Align Technology (ALGN)
www.americanbankingnews.com - August 24 at 10:26 PM
LivaNova PLC (LIVN) Receives Average Recommendation of "Hold" from AnalystsLivaNova PLC (LIVN) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - August 23 at 9:16 AM
Financial Review: LivaNova PLC (LIVN) & InspireMD (NSPR)Financial Review: LivaNova PLC (LIVN) & InspireMD (NSPR)
www.americanbankingnews.com - August 20 at 2:28 PM
LivaNova Plc breached its 50 day moving average in a Bearish Manner : LIVN-US : August 18, 2017LivaNova Plc breached its 50 day moving average in a Bearish Manner : LIVN-US : August 18, 2017
finance.yahoo.com - August 18 at 8:44 PM
Insider Selling: LivaNova PLC (LIVN) Director Sells 1,000 Shares of StockInsider Selling: LivaNova PLC (LIVN) Director Sells 1,000 Shares of Stock
www.americanbankingnews.com - August 17 at 10:24 AM
LivaNova Plc – Value Analysis (NASDAQ:LIVN) : August 17, 2017LivaNova Plc – Value Analysis (NASDAQ:LIVN) : August 17, 2017
finance.yahoo.com - August 17 at 1:52 AM
LivaNova PLC (LIVN) Downgraded to "Sell" at WBB SecuritiesLivaNova PLC (LIVN) Downgraded to "Sell" at WBB Securities
www.americanbankingnews.com - August 15 at 11:20 AM
LivaNova PLC (LIVN) Receives "Buy" Rating from Berenberg BankLivaNova PLC (LIVN) Receives "Buy" Rating from Berenberg Bank
www.americanbankingnews.com - August 12 at 5:42 PM
See what the IHS Markit Score report has to say about LivaNova PLC.See what the IHS Markit Score report has to say about LivaNova PLC.
finance.yahoo.com - August 12 at 2:39 AM
LivaNova PLC (NASDAQ:LIVN) Posts  Earnings Results, Beats Expectations By $0.19 EPSLivaNova PLC (NASDAQ:LIVN) Posts Earnings Results, Beats Expectations By $0.19 EPS
www.americanbankingnews.com - August 11 at 11:46 PM
LivaNova plc (LIVN) Tops Q2 EPS by 19c, Beats on Revenues; Reaffirms FY17 EPS Mid-Point Guidance Above ConsensusLivaNova plc (LIVN) Tops Q2 EPS by 19c, Beats on Revenues; Reaffirms FY17 EPS Mid-Point Guidance Above Consensus
www.streetinsider.com - August 10 at 2:26 AM

Social Media

Financials

Chart

LivaNova PLC (NASDAQ LIVN) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.